12-50104692-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005276.4(GPD1):āc.160A>Gā(p.Ile54Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00231 in 1,613,684 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_005276.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPD1 | NM_005276.4 | c.160A>G | p.Ile54Val | missense_variant | 2/8 | ENST00000301149.8 | NP_005267.2 | |
GPD1 | NM_001257199.2 | c.160A>G | p.Ile54Val | missense_variant | 2/8 | NP_001244128.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPD1 | ENST00000301149.8 | c.160A>G | p.Ile54Val | missense_variant | 2/8 | 1 | NM_005276.4 | ENSP00000301149 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0125 AC: 1906AN: 152234Hom.: 38 Cov.: 32
GnomAD3 exomes AF: 0.00338 AC: 849AN: 251448Hom.: 17 AF XY: 0.00230 AC XY: 313AN XY: 135900
GnomAD4 exome AF: 0.00124 AC: 1811AN: 1461332Hom.: 42 Cov.: 32 AF XY: 0.00104 AC XY: 756AN XY: 726984
GnomAD4 genome AF: 0.0125 AC: 1910AN: 152352Hom.: 38 Cov.: 32 AF XY: 0.0119 AC XY: 888AN XY: 74506
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 09, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
GPD1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 25, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at